Pandemic (H1N1) 2009 guidance documents
A
- Advice on the use of masks in the community setting in Influenza A(H1N1) outbreaks
- Availability of a candidate international standard for antibody to A/California/7/2009 (H1N1)v-like viruses
- Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development CBER-RG2
- Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development NIBRG-121
- Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development X-179A
- Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development: IDCDC-RG15
- Availability of a candidate reassortant vaccine virus for the novel influenza A(H1N1) vaccine development IVR-153
- Availability of a new candidate reassortant vaccine virus for pandemic (H1N1) 2009 vaccine development
- Availability of a new candidate reassortant vaccine virus for pandemic (H1N1) 2009 virus vaccine development NIBRG-121xp
- Availability of four new candidate reassortant vaccine viruses for pandemic (H1N1) 2009 virus vaccine development IDCDC-RG18, IDCDC-RG20, IDCDC-RG22 and NIBRG-122
- Availability of two new candidate reassortant vaccine viruses for pandemic (H1N1) 2009 virus vaccine development X-181 and X-181A
B
- Behavioural interventions for reducing the transmission and impact of influenza A(H1N1) virus: a framework for communication strategies
- Biocontainment requirements for vaccine production from and quality control of the reassortant candidate vaccine virus CBER-RG2
- Biocontainment requirements for vaccine production from and quality control of the reassortant candidate vaccine virus IVR-153
- Biocontainment requirements for vaccine production from and quality control of the reassortant vaccine candidate viruses IDCDC-RG15, NIBRG-121 and X-179A
C
- Call to action
- Case management of Influenza A(H1N1) in air transport
- CDC protocol of realtime RTPCR for influenza A (H1N1)
- Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development
- Clean hands protect against infection
- Clinical management of adult patients with complications of pandemic influenza A(H1N1) 2009 influenza: Emergency guidelines for the management of patients with severe respiratory distress and shock in district hospitals in limited-resource settings
- Clinical management of human infection with pandemic (H1N1) 2009: revised guidance
- Considerations of influenza A(H1N1) and HIV infection
- Consultation on potential risks of pandemic (H1N1) 2009 influenza virus at the human-animal interface
- Countries able to perform PCR to diagnose influenza A (H1N1) virus infection in humans
G
H
I
- Infection prevention and control in health care for confirmed or suspected cases of pandemic (H1N1) 2009 and influenza-like illnesses
- Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care
- Influenza A(H1N1) patient care checklist
- Instruction on how to obtain CDC realtime RT-PCR kits for detection of influenza A(H1N1)
- Instructions for storage and transport of suspected or confirmed human and animal specimens and virus isolates of pandemic (H1N1) 2009
- Interim planning considerations for mass gatherings in the context of pandemic (H1N1) 2009 influenza
P
- Pandemic influenza A (H1N1) 2009: considerations for tuberculosis care services
- Pandemic influenza A(H1N1) - draft donor report
- Pandemic influenza preparedness and mitigation in refugee and displaced populations. WHO guidelines for humanitarian agencies.
- Pandemic influenza preparedness and response
- Pandemic influenza prevention and mitigation in low resource communities
- Pregnancy and pandemic influenza A (H1N1) 2009: information for programme managers and clinicians
- Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses
- Protocol for antiviral susceptibility testing by pyrosequencing
R
S
- Safe transport of pandemic influenza A (H1N1) 2009 virus cultures, isolates and patient specimens as Biological Substance, Category B
- Sequencing primers and protocol
- Statement from WHO Global Advisory Committee on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 vaccines
- Status of candidate vaccine virus development for the current Influenza A(H1N1) virus
- Summary of available potency testing reagents for Pandemic (H1N1) 2009 virus vaccines
- Summary report of a High-Level Consultation: new influenza A (H1N1)
- Surveillance recommendations for Member States in the post-pandemic period
V
W
- WHO ad hoc scientific teleconference on the current influenza A(H1N1) situation
- WHO Consultation on suspension of classes and restriction of mass gatherings to mitigate the impact of epidemics caused by the new influenza A (H1N1)
- WHO Guidelines for Pharmacological Management of Pandemic (H1N1) 2009 Influenza and other Influenza Viruses
- WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans - revised
- WHO interim technical advice for case management of pandemic (H1N1) 2009 on ships
- WHO recommendations on influenza A(H1N1) vaccines
- WHO Technical Consultation on the Severity of Disease Caused by the new influenza A (H1N1) virus infections
